Home›People›Marc Panoff
MP

Marc Panoff

Senior Vice President, Finance at LB Pharmaceuticals.

ExecutivePublic company
Updated Nov 9, 2026·Latest SEC filing Sep 29, 2025·Suggest an edit

About Marc Panoff

Marc Panoff is a senior vice president, finance at LB Pharmaceuticals.

Marc Panoff reports to the SEC as an officer of 3 public companies, including Travere Therapeutics (TVTX) and Neurologix (NRGX.OB).

Marc Panoff first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Marc Panoff in the role, so the role may have started earlier or lasted longer.

LB Pharmaceuticals Inc.
Senior Vice President, Finance
2018 – 2025 · Public company (LBRX)
Travere Therapeutics, Inc.
Chief Financial Officer
2013 – 2014 · Public company (TVTX)
Neurologix Inc.
CFO, Treasurer & Secretary
2006 – 2011 · Public company (NRGX.OB)

Key Colleagues at Startups

The people Marc Panoff works with at each company, as listed on that company's latest Form D.

LB Pharmaceuticals Inc. · Form D/A, Jan 10, 2024
RJ
Rajul Jain
Director
RN
Ran Nussbaum
Director
ZP
Zachary Prensky
Chief Executive Officer and director
RR
AV
Andrew Vaino
Executive officer
AE
Anna Eramo
Executive officer
RL
Rebecca Luse
Director
CY
Chen Yu
Director

Sources

  1. SECLB Pharmaceuticals Inc. Form D/A, filed Jan 10, 2024
  2. SECForms 3, 4 and 5 filed by Marc Panoff (SEC filer 1304340)